Abstract
Objective: We present an interesting case of accidental overdose of latanoprost eye drops.
Case Report: A 71-year-old patient underwent an uncomplicated cataract surgery in his right eye. During the first postsurgical week he mistakenly used latanoprost eye drops six times daily instead of the prescribed tobramycin/dexamethasone eye drops. The patient experienced gradually decreasing visual acuity and was diagnosed with cystoid macular edema seven weeks after surgery. The cystoid macular edema resolved 4 weeks later after treatment with nepafenac 0.3% eye drops and oral acetazolamide. The cystoid macular edema recurred 2 weeks after rechallenge with latanoprost. The rechallenge-induced cystoid macular edema once again resolved after cessation of latanoprost and retreatment with nepafenac eye drops. A Naranjo assessment score of 7 was obtained, indicating a probable relationship between the patient’s symptoms and the suspect drug.
Keywords: Cystoid macular edema, uneventful phacoemulsification, latanoprost overdose, rechallenge, prostaglandin analogues, best corrected visual acuity, optical coherence tomography.
Graphical Abstract
Current Drug Safety
Title:Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification
Volume: 13 Issue: 3
Author(s): Olga E. Makri, Iasonas K. Tsekouras, Panagiotis Plotas, Foteini Tsapardoni, Athina Pallikari and Constantine D. Georgakopoulos*
Affiliation:
- Department of Ophthalmology, Medical School, University of Patras, Patras,Greece
Keywords: Cystoid macular edema, uneventful phacoemulsification, latanoprost overdose, rechallenge, prostaglandin analogues, best corrected visual acuity, optical coherence tomography.
Abstract: Objective: We present an interesting case of accidental overdose of latanoprost eye drops.
Case Report: A 71-year-old patient underwent an uncomplicated cataract surgery in his right eye. During the first postsurgical week he mistakenly used latanoprost eye drops six times daily instead of the prescribed tobramycin/dexamethasone eye drops. The patient experienced gradually decreasing visual acuity and was diagnosed with cystoid macular edema seven weeks after surgery. The cystoid macular edema resolved 4 weeks later after treatment with nepafenac 0.3% eye drops and oral acetazolamide. The cystoid macular edema recurred 2 weeks after rechallenge with latanoprost. The rechallenge-induced cystoid macular edema once again resolved after cessation of latanoprost and retreatment with nepafenac eye drops. A Naranjo assessment score of 7 was obtained, indicating a probable relationship between the patient’s symptoms and the suspect drug.
Export Options
About this article
Cite this article as:
Makri E. Olga , Tsekouras K. Iasonas , Plotas Panagiotis , Tsapardoni Foteini , Pallikari Athina and Georgakopoulos D. Constantine *, Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification, Current Drug Safety 2018; 13 (3) . https://dx.doi.org/10.2174/1574886313666180619163845
DOI https://dx.doi.org/10.2174/1574886313666180619163845 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Intrinsic Disorder in the Core Proteins of Flaviviruses
Protein & Peptide Letters Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls
Current Cardiology Reviews 3D Modeling of Dengue Virus NS4B and Chikungunya Virus nsP4: Identification of a Common Drug Target and Designing a Single Antiviral Inhibitor
Current Computer-Aided Drug Design A<sub>3</sub> Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes
Recent Patents on Cardiovascular Drug Discovery Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings
Current Drug Discovery Technologies HLA-G - From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases
Current Immunology Reviews (Discontinued) Artepillin C: A Review
Letters in Drug Design & Discovery Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Small Intestinal Injury Caused by NSAIDs/Aspirin: Finding New from Old
Current Medicinal Chemistry Monoclonal Antibodies - Regulatory Challenges
Current Pharmaceutical Biotechnology Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin
Current Topics in Medicinal Chemistry Mechanistic Approach to Understanding Psychosis Risk in Velocardiofacial Syndrome
Current Pediatric Reviews Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design Hypersensitivity Reactions to Anticoagulant Drugs
Current Pharmaceutical Design The Clinical Effectiveness of Magnets for People with Osteoarthritis: A Systematic Review and Meta-analysis
Current Rheumatology Reviews Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research Highly Efficient Proteolysis Accelerated by Electromagnetic Waves for Peptide Mapping
Current Genomics Syncytin and GCMa: Key Regulators in Human Placental Physiology and in Pre-Eclampsia
Current Women`s Health Reviews Small Molecule Approaches Toward the Non-Microbicidal Modulation of Bacterial Biofilm Growth and Maintenance
Anti-Infective Agents in Medicinal Chemistry